Armor Investment Advisors, LLC Bristol Myers Squibb CO Transaction History

Armor Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $7,425 - $8,421	-113 Reduced 0.92%	12,137 $841,000
Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $13,696 - $16,218	200 Added 1.66%	12,250 $881,000
Q4 2021 Feb 07, 2022	SELL	$53.63 - $62.52 $10,404 - $12,128	-194 Reduced 1.58%	12,050 $751,000
Q2 2020 Aug 04, 2020	BUY	$54.82 - $64.09 $2,741 - $3,204	50 Added 0.41%	12,244 $720,000
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $4,640 - $6,743	-100 Reduced 0.81%	12,194 $680,000
Q3 2018 Nov 05, 2018	SELL	$55.19 - $62.25 $5,519 - $6,225	-100 Reduced 0.81%	12,294 $763,000
Q4 2017 Feb 01, 2018	SELL	$59.94 - $65.35 $4,135 - $4,509	-69 Reduced 0.55%	12,394 $760,000
Q3 2017 Nov 02, 2017	SELL	$55.23 - $63.74 $6,075 - $7,011	-110 Reduced 0.87%	12,463 $794,000
Q2 2017 Aug 09, 2017	BUY	N/A	12,573	12,573 $701,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Armor Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Armor Investment Advisors, LLC with notifications on news.